272 related articles for article (PubMed ID: 23623990)
1. Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease.
St Laurent R; O'Brien LM; Ahmad ST
Neuroscience; 2013 Aug; 246():382-90. PubMed ID: 23623990
[TBL] [Abstract][Full Text] [Related]
2. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.
Coulom H; Birman S
J Neurosci; 2004 Dec; 24(48):10993-8. PubMed ID: 15574749
[TBL] [Abstract][Full Text] [Related]
3. Diet with Low Molecular Weight Chitosan exerts neuromodulation in Rotenone induced Drosophila model of Parkinson's disease.
Pramod Kumar P; Harish Prashanth KV
Food Chem Toxicol; 2020 Dec; 146():111860. PubMed ID: 33212211
[TBL] [Abstract][Full Text] [Related]
4. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI
Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965
[TBL] [Abstract][Full Text] [Related]
5. Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster.
Li W; Pan X; Li M; Ling L; Zhang M; Liu Z; Zhang K; Guo J; Wang H
Neurosci Lett; 2023 May; 805():137187. PubMed ID: 36921666
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.
Monti B; Gatta V; Piretti F; Raffaelli SS; Virgili M; Contestabile A
Neurotox Res; 2010 Feb; 17(2):130-41. PubMed ID: 19626387
[TBL] [Abstract][Full Text] [Related]
7. Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson's disease model.
Stephano F; Nolte S; Hoffmann J; El-Kholy S; von Frieling J; Bruchhaus I; Fink C; Roeder T
Sci Rep; 2018 Feb; 8(1):2372. PubMed ID: 29403026
[TBL] [Abstract][Full Text] [Related]
8. A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease.
Varga SJ; Qi C; Podolsky E; Lee D
Brain Res; 2014 Oct; 1583():277-86. PubMed ID: 25130663
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and neurochemical effects of sodium butyrate in an animal model of mania.
Moretti M; Valvassori SS; Varela RB; Ferreira CL; Rochi N; Benedet J; Scaini G; Kapczinski F; Streck EL; Zugno AI; Quevedo J
Behav Pharmacol; 2011 Dec; 22(8):766-72. PubMed ID: 21989497
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective potential of cinnamoyl derivatives against Parkinson's disease indicators in Drosophila melanogaster and in silico models.
Tibashailwa N; Stephano F; Shadrack DM; Munissi JJE; Nyandoro SS
Neurotoxicology; 2023 Jan; 94():147-157. PubMed ID: 36410467
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity.
Sharma S; Taliyan R; Singh S
Behav Brain Res; 2015 Sep; 291():306-314. PubMed ID: 26048426
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease.
Bayersdorfer F; Voigt A; Schneuwly S; Botella JA
Neurobiol Dis; 2010 Oct; 40(1):113-9. PubMed ID: 20211259
[TBL] [Abstract][Full Text] [Related]
14. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
[TBL] [Abstract][Full Text] [Related]
15. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
[TBL] [Abstract][Full Text] [Related]
16. Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
Cicchetti F; Drouin-Ouellet J; Gross RE
Trends Pharmacol Sci; 2009 Sep; 30(9):475-83. PubMed ID: 19729209
[TBL] [Abstract][Full Text] [Related]
17. Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation.
Du G; Liu X; Chen X; Song M; Yan Y; Jiao R; Wang CC
Mol Biol Cell; 2010 Jul; 21(13):2128-37. PubMed ID: 20444973
[TBL] [Abstract][Full Text] [Related]
18. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity.
Srivastav S; Neupane S; Bhurtel S; Katila N; Maharjan S; Choi H; Hong JT; Choi DY
J Nutr Biochem; 2019 Jul; 69():73-86. PubMed ID: 31063918
[TBL] [Abstract][Full Text] [Related]
19. Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration.
Morais LH; Lima MM; Martynhak BJ; Santiago R; Takahashi TT; Ariza D; Barbiero JK; Andreatini R; Vital MA
Pharmacol Rep; 2012; 64(5):1081-90. PubMed ID: 23238465
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.
Khadrawy YA; Salem AM; El-Shamy KA; Ahmed EK; Fadl NN; Hosny EN
J Diet Suppl; 2017 Sep; 14(5):553-572. PubMed ID: 28301304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
